Amarin to Present at H.C. Wainwright 2nd Annual BioConnect Investor Conference
Amarin to Present at H.C. Wainwright 2nd Annual BioConnect Investor Conference
Amarin to Present at H.C. Wainwright 2nd Annual BioConnect Investor Conference
Amarin Corporation plc (NASDAQ:AMRN) Q1 2024 Earnings Call Transcript
Kymera (KYMR) Q1 Loss Narrower Than Expected, Pipeline in Focus
Is Amarin (AMRN) Stock Outpacing Its Medical Peers This Year?
Is Amarin (AMRN) Stock Outpacing Its Medical Peers This Year?
Bausch (BHC) Q1 Earnings and Revenues Miss, Shares Fall
Amarin First Quarter 2024 Earnings: EPS Beats Expectations
Q1 2024 Amarin Corporation PLC Earnings Call Transcript
Amarin's (AMRN) Q1 Earnings and Revenues Surpass Estimates
Amarin's (AMRN) Q1 Earnings and Revenues Surpass Estimates
Amarin Plc (AMRN) Q1 2024 Earnings Call Transcript
Amarin’s Sell Rating Affirmed Amid US Market Challenges and Uncertain European Growth
Amarin’s Sell Rating Affirmed Amid US Market Challenges and Uncertain European Growth
Exelixis (EXEL) Q1 Earnings Miss, Cabometyx Sales Fall Short
Amarin Corp PLC (AMRN) Q1 2024 Earnings: Navigating Challenges with Strategic Focus
Amarin Corp PLC (AMRN) Q1 2024 Earnings: Navigating Challenges with Strategic Focus
Amarin Reports First Quarter 2024 Business Update and Financial Results
Amarin Applauds HealthyWomen's Citizen's Petition Urging FDA To Take Further Action On Fenofibrate Prescribing in Patients at Risk of Cardiovascular Event
•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.